NTBI levels in C282Y homozygotes after therapeutic phlebotomy-Reference-Cited by-同舟云学术

NTBI levels in C282Y homozygotes after therapeutic phlebotomy

Published:2022-07-27 Issue:3 Volume:3 Page:644-652
ISSN:2688-6146
Container-title:eJHaem
language:en
Short-container-title:eJHaem

Author:

Ryan Eleanor¹^ORCID,Mulready Keith²,Wiegerinck Erwin³,Russell Jennifer¹,Swinkels Dorine W.³^ORCID,Stewart Stephen¹^ORCID

Affiliation:

1. Liver Centre Mater Misericordiae University Hospital Dublin Ireland

2. Department of Biochemistry and Diagnostic Endocrinology Mater Misericordiae University Hospital Dublin Ireland

3. Laboratory of Genetic, Endocrine and Metabolic Diseases, Department of Laboratory Medicine Radboud University Medical Centre Nijmegen The Netherlands

Publisher

Wiley

Subject

General Earth and Planetary Sciences

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jha2.507

Reference37 articles.

1. A novel MHC class I–like gene is mutated in patients with hereditary haemochromatosis

2. Hemochromatosis in Ireland and HFE

3. Disrupted hepcidin regulation in HFE -associated haemochromatosis and the liver as a regulator of body iron homoeostasis

4. Serum hepcidin levels are innately low inHFE-related haemochromatosis but differ between C282Y-homozygotes with elevated and normal ferritin levels

5. Hepcidin Regulates Cellular Iron Efflux by Binding to Ferroportin and Inducing Its Internalization

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rusfertide for the treatment of iron overload in HFE-related haemochromatosis: an open-label, multicentre, proof-of-concept phase 2 trial;The Lancet Gastroenterology & Hepatology;2023-12

2. Haemochromatosis;The Lancet;2023-05

3. The clinical relevance of detectable plasma iron species in iron overload states and subsequent to intravenous iron‐carbohydrate administration;American Journal of Hematology;2023-01-09